Wall Street Journal reported that prosecutors had opened a criminal investigation into the Canadian drugmaker
Valeant Pharmaceuticals International Inc.’s (TSE:VRX) U.S.-listed stock fell about 10 percent in premarket trading on Thursday after the Wall Street Journal reported that prosecutors had opened a criminal investigation into the Canadian drugmaker.
Lawyers at the U.S. Attorney’s Manhattan office are probing whether Valeant obscured from insurers its relationship with a specialty pharmacy that helped inflate its drug sales, the Journal reported on Wednesday, citing sources.
Read the full article at: ca.finance.yahoo.com
